2019-06 TRISCEND Study

Key Inclusion Criteria: * Functional or degenerative TR moderate or greater * Symptomatic despite medical therapy or prior HF hospitalization from TR * The Local Site Heart Team determines that the patient is appropriate for transcatheter tricuspid valve replacement Key Exclusion Criteria: * Tricuspid valve anatomic contraindications * Need for emergent or urgent surgery or any planned cardiac surgery within the next 12 months * Hemodynamic instability * Refractory heart failure requiring advanced intervention * Currently participating in another investigational study in which the patient has not reached a primary endpoint